Clinical Trials List
2023-03-08 - 2025-12-31
Phase II
Not yet recruiting4
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Hung-Wei Wang Digestive System Department
- Chih-Yen Tu Division of Thoracic Medicine
- Hsueh-Chou Lai Digestive System Department
- Li-Yuan Bai Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Su-Peng Yeh Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 陳鴻仁 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tien-Hua Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 莊建淮 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yu-Chieh Tsai Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- FU-JEN HSUEH Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chien-Jui Huang Division of General Internal Medicine
- 劉奕廷 Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6-8 participants
-
Global
40-60 participants
